Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024270
Filing Date
2021-06-16
Accepted
2021-06-16 19:31:11
Documents
2
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2175
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4725
  Complete submission text file 0000899243-21-024270.txt   8242
Mailing Address C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVE BEDFORD MA 01730
Business Address
Ticho Barry (Reporting) CIK: 0001780088 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40489 | Film No.: 211022899

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations